Atypical hemolytic uremic syndrome: the role of complement pathway gene mutation analysis.
نویسنده
چکیده
IW The complement system is a part of the innate immune system that is necessary for fighting infections and aberrant immunologic stimuli. Complement has 2 main functions. One function is opsonization: coating pathogens—such as bacteria, viruses, and dead cells— with C3b for macrophage clearance. The other function is cell lysis; that is, punching a hole in the membrane of a cell or pathogen. People who have a mutation in a complement regulatory protein do not have adequate capacity to limit complement activation. Some of the triggers for upregulation of complement activity are bacterial and viral infections, antigen-antibody complexes, autoimmunity, vaccination, pregnancy, and surgery. There may be a threshold for complement activation above which people who have some abnormality in their complement regulatory proteins become symptomatic. H&O Which mutations in complement alternative pathway genes are linked to aHUS?
منابع مشابه
Preemptive Use of Eculizumab for Living - Donor Kidney Transplantation in a Child with Atypical Hemolytic Uremic Syndrome
INTRODUCTION Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy characterized by overactivation of the alternative complement pathway. This syndrome is associated with severe clinical manifestations, a tendency to recur, and, until recently, a poor long-term prognosis (Noris & Remuzzi, 2009). With conventional supportive therapy, the expected rate of graft failure af...
متن کاملDelta beta thalassemia: a rare hemoglobin variant
Abbreviations: CBC, complete blood count; Hb, hemoglobin; HPLC, high-performance liquid chromatography. 2011;26:162-5. 7. Cho HY, Lee BS, Moon KC, Ha IS, Cheong HI, Choi Y. Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate. Pediatr Nephrol 2007;22:874-80. 8. Frémeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to developm...
متن کاملComprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy caused by uncontrolled activation of the alternative pathway of complement at the cell surface level that leads to microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney failure. In approximately one half of affected patients, pathogenic loss-of-function variants in regulators of complement or gain-of-funct...
متن کاملDiabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report
BACKGROUND Non-Shiga toxin-associated hemolytic uremic syndrome is known to be caused by dysregulation of the alternative complement pathway. Infections, drugs, pregnancy, bone marrow transplantation, malignancy, and autoimmune disorders have all been reported to trigger episodes of atypical hemolytic uremic syndrome. To the best of our knowledge, there have been no previous reports of an assoc...
متن کاملGain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
Hemolytic uremic syndrome (HUS) is an important cause of acute renal failure in children. Mutations in one or more genes encoding complement-regulatory proteins have been reported in approximately one-third of nondiarrheal, atypical HUS (aHUS) patients, suggesting a defect in the protection of cell surfaces against complement activation in susceptible individuals. Here, we identified a subgroup...
متن کاملAtypical hemolytic uremic syndrome
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Most cases of aHUS are caused by uncontrolled complement activation due to genetic mutations in the alternative pathway of complement. More recently, mutations in the gene of coagulation system have also been identified in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical advances in hematology & oncology : H&O
دوره 12 4 شماره
صفحات -
تاریخ انتشار 2014